GSK and CureVac join forces to develop vaccines targeting new COVID-19 variants
February 03, 2021 at 04:45 AM EST
GSK and CureVac said their approach could potentially tackle multiple coronavirus strains in one vaccine shot
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|